Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases;Baja prevalencia de anticuerpos antifosfolipidos autoinmunes en enfermedades hepaticas

Medicina

Volumn 60, Issue 6, 2000, Pages 919-922

  De Larrañaga, Gabriela F ^a,b   Harris, E Nigel ^c   Pierangeli, Silvia S ^c   Alonso, Beatriz S ^a   Schroder, Teresa ^b   Fainboim, Hugo ^b  

^a Sección Bioquímica   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

^c Hosp Enferm Infecciosas FJ Muniz ^*

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Autoimmune hepatitis; Hepatitis B; Hepatitis C

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOLOGY; PREVALENCE;

ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREVALENCE;

EID: 0042366294     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An Update. Thromb Haemost 1995; 74: 1185-90.
2. Harris EN, Pierangeli SS, Birch D. Anticardiolipin Wet Workshop Report. Fifth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol 1994; 101: 616-24.
3. Horbach DA, Gort EV, Donders RCJM, Derksen RHWM, Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996; 76: 916-24.
4. Harris EN. The antiphospholipid syndrome - an introduction. In: Phospholipid Antibodies. Harris EN, et al. (eds) Boca Raton: CRC Press 1991; 373-86.
5. Meyer O, Cyna L, Bourgeois P, Kahn MF, Ryckewaert A. Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis. Clin Rheumatol 1937; 6: 369-77.
6. Santiago MB, Cossmelli W, Tuma MF, Oliveira RM. Anticardiolipin antibodies in infectious diseases. Clin Rheumatol 1989; 8: 23-8.
7. Labarca JA, Rabaggliatti RM, Radrigan FJ, et al. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997; 24: 197-200.
8. Montagud M, Muñiz Díaz E, Fontcuberta J, Anticoagulante lúpico y anticuerpos anticardiolipina en la infección por el virus de la inmunodeficiencia humana. Biol Clin Hematol 1991; 13: 57-62.
9. Al Saeed A, Makris M, Malia RG, Preston FE, Greaves M. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haemat 1994; 88: 854-8.
10. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) direct not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
11. 2-Glycoprotein I in the absence of phospholipid. J Immunology 1995; 154: 954-60.
12. 2-Glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
13. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other antiphospholipid autoantibodies. Blood1994; 84: 2854-67.
14. 2-Glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost 1996; 75: 717-20.
15. th International Symposium on Antiphospholipid Antibodies. J Rheumatol 1998; 25: 156-60.
16. Harris EN, Pierangeli SS. A more specific ELISA assay for the detection of antiphospholipid antibodies. Clin Immunol Newsletter 1995; 15: 26-8.
17. Merkel PA, Chang Y, Pierangeli SS, Harris EN, Polisson RP. Comparison between the standart anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. J Rheumatol 1999; 26: 591-6.
18. Toulon P, Gris JC, Salomon D, et al. Antiphospholipid antibodies in HIV-infected patients are not associated with a prothrombotic state. Nouv Rev Hematol 1995; 37: s97 s101.
19. Gotch M, Matsuda J. Human immunodeficiency virus rather than Hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody. Am J Hematol 1995; 50: 220-2.
20. Levy RA, Azzudin F, Gharavi Sammaritano LR, et al.: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. J Rheumatol 1990; 17: 1036-41.
21. 2-Glycoprotein I autoantibodies and its relevance to anticardiolipin antibodies quantitation. Thromb Haemost 1996, 75: 725-30.
22. 2-Glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-5.
23. Sekigawa I, Kaneko H, Hishikawa T, et al. HIV infection and SLE: Their pathogenic relationship. Clin Exp Rheumatol 1998; 16: 175-80.
24. Hadziyannis S. Nonhepatic manifestations and combined diseases in HCV infection. Digest Dis Sciences 1996; 41: 635-745.
25. Chedid A, Chadalawada KR, Morgan TR, et al. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994; 1465-71.
26. Makris M, Preston FE, Triger DR, Underwood JCE. Hepatitis C antibodies and chronic liver disease in haemophilia. Lancet 1990; 335: 1117-9.
27. Matsuda J, Saitoh N, Gotch M, et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibodies in patients with Hepatitis C virus infection treated with Interferon a. Am J Gastroenterology 1995; 90: 1138-41.
28. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic Hepatitis C: Implication of Hepatitis C virus as the cause of the antiphospholipid syndrome Hepatology 1996; 23: 199-204.